Literature DB >> 23550939

Modeling poliovirus risks and the legacy of polio eradication.

Kimberly M Thompson1.   

Abstract

This introduction to the special issue on modeling poliovirus risks provides context about historical efforts to manage polioviruses and reviews the insights from models developed to support risk management and policy development. Following an overview of the contents of the special issue, the introduction explores the road ahead and offers perspective on the legacy of polio eradication.
© 2013 Society for Risk Analysis.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23550939      PMCID： PMC7896538          DOI： 10.1111/risa.12030

Source DB:  PubMed          Journal:  Risk Anal        ISSN： 0272-4332            Impact factor:   4.000


  27 in total

1.  Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.

Authors:  Kimberly M Thompson; Gregory S Wallace; Radboud J Duintjer Tebbens; Philip J Smith; Albert E Barskey; Mark A Pallansch; Kathleen M Gallagher; James P Alexander; Gregory L Armstrong; Stephen L Cochi; Steven G F Wassilak
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  The role of risk analysis in polio eradication: modeling possibilities, probabilities and outcomes to inform choices.

Authors:  Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

3.  Development of an individual-based model for polioviruses: implications of the selection of network type and outcome metrics.

Authors:  H Rahmandad; K Hu; R J Duintjer Tebbens; K M Thompson
Journal:  Epidemiol Infect       Date:  2010-07-12       Impact factor: 2.451

Review 4.  Polio eradication from the Western Hemisphere.

Authors:  C A de Quadros; J K Andrus; J M Olive; C Guerra de Macedo; D A Henderson
Journal:  Annu Rev Public Health       Date:  1992       Impact factor: 21.981

5.  Evaluation of response scenarios to potential polio outbreaks using mathematical models.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch
Journal:  Risk Anal       Date:  2006-12       Impact factor: 4.000

6.  Public health. Is polio eradication realistic?

Authors:  Isao Arita; Miyuki Nakane; Frank Fenner
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

7.  New strategies for the elimination of polio from India.

Authors:  Nicholas C Grassly; Christophe Fraser; Jay Wenger; Jagadish M Deshpande; Roland W Sutter; David L Heymann; R Bruce Aylward
Journal:  Science       Date:  2006-11-17       Impact factor: 47.728

8.  Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.

Authors:  Radboud J Duintjer Tebbens; Kimberly M Thompson; M G Myriam Hunink; Thomas A Mazzuchi; Daniel Lewandowski; Dorota Kurowicka; Roger M Cooke
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

9.  The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  Medscape J Med       Date:  2008-08-13

10.  A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks.

Authors:  Kathleen M O'Reilly; Claire Chauvin; R Bruce Aylward; Chris Maher; Sam Okiror; Chris Wolff; Deo Nshmirimana; Christl A Donnelly; Nicholas C Grassly
Journal:  PLoS Med       Date:  2011-10-18       Impact factor: 11.069
View more
  7 in total

1.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

2.  Comparative epidemiology of poliovirus transmission.

Authors:  Navideh Noori; John M Drake; Pejman Rohani
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

3.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

4.  Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.

Authors:  J S Koopman; C J Henry; J H Park; M C Eisenberg; E L Ionides; J N Eisenberg
Journal:  Epidemics       Date:  2017-03-01       Impact factor: 4.396

5.  Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative.

Authors:  Kimberly M Thompson; Dominika A Kalkowska; Kamran Badizadegan
Journal:  Gates Open Res       Date:  2022-02-03

Review 6.  Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Risk Anal       Date:  2020-04-27       Impact factor: 4.000

Review 7.  Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Expert Rev Vaccines       Date:  2020-08-01       Impact factor: 5.217
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.